Related papers: TrialGraph: Machine Intelligence Enabled Insight f…
The widespread application of machine learning techniques to biomedical data has produced many new insights into disease progression and improving clinical care. Inspired by the flexibility and interpretability of graphs (networks), as well…
The quest for accurate prediction of drug molecule properties poses a fundamental challenge in the realm of Artificial Intelligence Drug Discovery (AIDD). An effective representation of drug molecules emerges as a pivotal component in this…
Analyzing machine learning model performance stratified by patient and recording properties is becoming the accepted norm and often yields crucial insights about important model failure modes. Performing such analyses in a statistically…
Treatment effect estimation, which helps understand the causality between treatment and outcome variable, is a central task in decision-making across various domains. While most studies focus on treatment effect estimation on individual…
Our work introduces an innovative approach to graph learning by leveraging Hyperdimensional Computing. Graphs serve as a widely embraced method for conveying information, and their utilization in learning has gained significant attention.…
The growing enforcement of the right to be forgotten regulations has propelled recent advances in certified (graph) unlearning strategies to comply with data removal requests from deployed machine learning (ML) models. Motivated by the…
Graph classification is a highly impactful task that plays a crucial role in a myriad of real-world applications such as molecular property prediction and protein function prediction.Aiming to handle the new classes with limited labeled…
This work presents the development and evaluation of an NLP-enabled probabilistic classifier designed to estimate the probability of technical and regulatory success (pTRS) for clinical trials in the field of neuroscience. While…
Automated classification of clinical transcriptions into medical specialties is essential for routing, coding, and clinical decision support, yet prior work on the widely used MTSamples benchmark suffers from severe data leakage caused by…
Clinical diagnosis, which aims to assign diagnosis codes for a patient based on the clinical note, plays an essential role in clinical decision-making. Considering that manual diagnosis could be error-prone and time-consuming, many…
Accurately predicting drug-target interactions (DTIs) is pivotal for advancing drug discovery and target validation techniques. While machine learning approaches including those that are based on Graph Neural Networks (GNN) have achieved…
Many large-scale applications can be elegantly represented using graph structures. Their scalability, however, is often limited by the domain knowledge required to apply them. To address this problem, we propose a novel Causal Temporal…
We present new methods for multilabel classification, relying on ensemble learning on a collection of random output graphs imposed on the multilabel and a kernel-based structured output learner as the base classifier. For ensemble learning,…
In this paper, we demonstrate that considering experiments in a graph-theoretic manner allows us to exploit automorphisms of the graph to reduce the number of evaluations of candidate designs for those experiments, and thus find optimal…
We present the Temporal Graph Benchmark (TGB), a collection of challenging and diverse benchmark datasets for realistic, reproducible, and robust evaluation of machine learning models on temporal graphs. TGB datasets are of large scale,…
Graph machine learning models often achieve similar overall performance yet behave differently at the node level, failing on different subsets of nodes with varying reliability. Standard evaluation metrics such as accuracy obscure these…
The increasing prevalence of graph-structured data across various domains has intensified greater interest in graph classification tasks. While numerous sophisticated graph learning methods have emerged, their complexity often hinders…
Drug repurposing (or repositioning) is the process of finding new therapeutic uses for drugs already approved by drug regulatory authorities (e.g., the Food and Drug Administration (FDA) and Therapeutic Goods Administration (TGA)) for other…
In deep neural networks, better results can often be obtained by increasing the complexity of previously developed basic models. However, it is unclear whether there is a way to boost performance by decreasing the complexity of such models.…
Causal structure learning from observational data remains a non-trivial task due to various factors such as finite sampling, unobserved confounding factors, and measurement errors. Constraint-based and score-based methods tend to suffer…